The Valley Desk

NCT04921345 · Interventional trial

Pharmacokinetics, Safety and Efficacy of Nemolizumab in Participants With Moderate-to-Severe Atopic Dermatitis

Overall registry status Completed

Phase 2

Conditions Moderate-to-Severe Atopic Dermatitis

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov